A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3–4 CKD
Author(s) -
Rajiv Saran,
Robin L. Padilla,
Brenda W. Gillespie,
Michael Heung,
Scott L. Hummel,
Vimal K. Derebail,
Bertram Pitt,
Nathan W. Levin,
Fansan Zhu,
Samer R. Abbas,
Li Liu,
Peter Kotanko,
Philip J. Klemmer
Publication year - 2017
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01120216
Subject(s) - medicine , crossover study , confidence interval , bioelectrical impedance analysis , blood pressure , creatinine , renal function , kidney disease , randomized controlled trial , extracellular fluid , gastroenterology , body mass index , urology , endocrinology , placebo , alternative medicine , pathology , extracellular , microbiology and biotechnology , biology
Patients with chronic kidney disease (CKD) are often volume expanded and hypertensive. Few controlled studies have assessed the effects of a sodium-restricted diet (SRD) in CKD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom